Keywords
Hyperthermic Intraperitoneal Chemotherapy
Intensive Care Units
Postoperative Period
Nursing Care Procedimentos Cirúrgicos de Citorredução
Quimioterapia Intraperitoneal Hipertérmica
Unidades de Terapia Intensiva
Período Pós-Operatório
Cuidados de Enfermagem
PlumX Metrics
Abstract
Objective: Mapping of postoperative nursing care indicated for adult and elderly critically ill patients hospitalized in intensive care units (ICUs) after Cytoreductive Surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC). Method: This is a scoping review protocol using the Joanna Briggs Institute methodology to address the research question "What postoperative nursing care is indicated for adult and elderly critically ill patients admitted to the ICU after cytoreductive surgery with HIPEC?". Evidence sources will be extracted from the Medical Literature Analysis and Retrieval System Online (MEDLINE), Cumulative Index to Nursing & Allied Health (CINAHL), SCOPUS, Embase, Biblioteca Virtual em Saúde (BVS), Cochrane Central Register of Controlled Trials (CENTRAL), and Web of Science. The Preferred Reporting Items for Systematic Reviews and Meta-Analyses extension for Scoping Reviews (PRISMA-ScR) checklist will be used to ensure the quality and transparency of reporting. All steps will be performed by two independent researchers using EndNote® and Rayyan®. The results extracted from the included studies will be presented in a descriptive narrative form.
References
Tsuyoshi H, Inoue D, Kurokawa T, Yoshida Y. Hyperthermic intraperitoneal chemotherapy (HIPEC) for gynecological cancer. J Obstet Gynaecol Res. 2020;46(9):1661-71. https://doi.org/10.1111/jog.14391
Kusamura S, Barretta F, Yonemura Y, Sugarbaker PH, Moran BJ, Levine EA, et al. The Role of Hyperthermic Intraperitoneal Chemotherapy in Pseudomyxoma Peritonei After Cytoreductive Surgery. JAMA Surg. 2021;156(3):e206363. https://doi.org/10.1001/jamasurg.2020.6363
Spiliotis J, Kalles V, Kyriazanos I, Terra A, Prodromidou A, Raptis A, et al. CRS and HIPEC in patients with peritoneal metastasis secondary to colorectal cancer: the small-bowel PCI score as a predictor of survival. Pleura Peritoneum. 2019;4(4):20190018. https://doi.org/10.1515%2Fpp-2019-0018
Rodríguez-Ortiz L, Arjona-Sánchez A, Ibañez-Rubio M, Sánchez-Hidalgo J, Casado-Adam A, Rufián-Peña S, et al. Laparoscopic cytoreductive surgery and HIPEC: a comparative matched analysis. Surg Endosc. 2021;35(4):1778-85. https://doi.org/10.1007/s00464-020-07572-x
Wang Y, Ren F, Chen P, Liu S, Song Z, Ma X. Effects of CytoReductive surgery plus hyperthermic IntraPEritoneal chemotherapy (HIPEC) versus CytoReductive surgery for ovarian cancer patients: A systematic review and meta-analysis. Eur J Surg Oncol. 2019; 45(3):301-309. https://doi.org/10.1016/j.ejso.2018.10.528
Narasimhan V, Wilson K, Britto M, Warrier S, Lynch AC, Michael M, et al. Outcomes following cytoreduction and HIPEC for Pseudomyxoma Peritonei: 10-year experience. J Gastrointest Surg. 2020;24(4):899-906. https://doi.org/10.1007/s11605-019-04239-4
Chawla A, Zhu C-C, Backer G, O'Gara J, Fong ZV, Deng H, et al. Perioperative management of patients undergoing CRS and HIPEC. Clin Surg [Internet]. 2020 [citado 2023 Ago 20];5:2788. Disponível em: https://www.clinicsinsurgery.com/open-access/perioperative-management-of-patients-undergoing-crs-and-hipec-7630.pdf
Charo LM, Jou J, Binder P, Hohmann SF, Saenz C, McHale M, et al. Current status of hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer in the United States. Gynecol Oncol. 2020;159(3):681-6. https://doi.org/10.1016/j.ygyno.2020.09.022
Cianci S, Riemma G, Ronsini C, De Franciscis P, Torella M, Schiattarella A, et al. Hyperthermic intraperitoneal chemotherapy (HIPEC) for ovarian cancer recurrence: systematic review and meta-analysis. Gland Surg [Internet]. 2020 [citado 2023 Ago 20];9(4):1140–8. Disponível em: https://pubmed.ncbi.nlm.nih.gov/32953629/
Mishra M, Singh N, Ghatage P. Past, present, and future of hyperthermic intraperitoneal chemotherapy (HIPEC) in ovarian cancer. Cureus. 2021;13(6):e15563. https://doi.org/10.7759/cureus.15563
Solanki SL, Mukherjee S, Agarwal V, Thota RS, Balakrishnan K, Shah SB, et al. Society of Onco-Anaesthesia and Perioperative Care consensus guidelines for perioperative management of patients for cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS-HIPEC). Indian J Anaesth. 2019;63(12):972-87. https://doi.org/10.4103/ija.ija_765_19
Rose L, Muttalib F, Adhikari NKJ. Psychological Consequences of Admission to the ICU: Helping Patients and Families. JAMA. 2019;322(3):213–215. https://doi.org/10.1001/jama.2019.9059
Vieira TW, Sakamoto VTM, Moraes LC, Blatt CR, Caregnato, RCA. Validation methods of nursing care protocols: an integrative review. Rev Bras Enferm. 2020;73(Suppl 5):e20200050 https://doi.org/10.1590/0034-7167-2020-0050
Dunn D, Ciccarelli E, Moltzen N. Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy, Part II: Implementation. AORN J. 2019;110(6):606-625. https://doi.org/10.1002/aorn.12865
Li D, Huang S, Zhang F, Ball RD, Huang H. Perianesthesia Care of the Oncologic Patient Undergoing Cytoreductive Surgery with Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Study. J Perianesth Nurs. 2021;36(5):543-552. https://doi.org/10.1016/j.jopan.2020.10.016
Seibæk L, Thaysen HV, Lomborg KE. Non-curative surgical oncology: postoperative needs and preferences. BMJ Support Palliat Care. 2021;3:bmjspcare-2020-002789. https://doi.org/10.1136/bmjspcare-2020-002789
Peters MDJ, Godfrey C, McInerney P, Munn Z, Tricco AC, Khalil H. Chapter 11: Scoping reviews (2020 version). In: Aromataris E, Munn Z, Editors. JBI manual for evidence synthesis. Adelaide: JBI, 2020. [citado 2023 Ago 20]. Disponível em: https://jbi-global-wiki.refined.site/space/MANUAL
Tricco AC, Lillie E, Zarin W, O’Brien K, Colquhoun H, Levac D, et al. PRISMA extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann Intern Med. 2018;169(7):467-73. https://doi.org/10.7326/m18-0850
Page MJ, McKenzie JE, Bossuyt PM, Boutron I, Hoffmann TC, Mulrow CD, et al. The PRISMA 2020 statement: an updated guideline for reporting systematic reviews. BMJ. 2021;372(71). https://doi.org/10.1136/bmj.n71
This work is licensed under a Creative Commons Attribution 4.0 International License.
Copyright (c) 2025 Array